View in EDS HTML Full Text PDF Full Text

Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial.

Saved in:
Bibliographic Details
Title: Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial.
Authors: Chew KW; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., McGinley B; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA., Moser C; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Li JZ; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Evering TH; Department of Medicine, Weill Cornell Medicine, New York, New York, USA., Ritz J; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Javan AC; Division of AIDS/National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA., Margolis D; Brii Biosciences, Durham, North Carolina, USA., Wohl DA; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Hughes MD; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA., Daar ES; Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA., Currier JS; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Eron JJ; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA., Smith DM; Department of Medicine, University of California, San Diego, La Jolla, California, USA.
Corporate Authors: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-2/A5401 Study Team, Study Sites, and Investigators
Source: The Journal of infectious diseases [J Infect Dis] 2025 Feb 04; Vol. 231 (1), pp. 131-136.
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39400063
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Chew+KW%22">Chew KW</searchLink>; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22McGinley+B%22">McGinley B</searchLink>; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Moser+C%22">Moser C</searchLink>; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Li+JZ%22">Li JZ</searchLink>; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Evering+TH%22">Evering TH</searchLink>; Department of Medicine, Weill Cornell Medicine, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Ritz+J%22">Ritz J</searchLink>; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Javan+AC%22">Javan AC</searchLink>; Division of AIDS/National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Margolis+D%22">Margolis D</searchLink>; Brii Biosciences, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Wohl+DA%22">Wohl DA</searchLink>; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Hughes+MD%22">Hughes MD</searchLink>; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Daar+ES%22">Daar ES</searchLink>; Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California, USA.<br /><searchLink fieldCode="AU" term="%22Currier+JS%22">Currier JS</searchLink>; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.<br /><searchLink fieldCode="AU" term="%22Eron+JJ%22">Eron JJ</searchLink>; Department of Medicine, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Smith+DM%22">Smith DM</searchLink>; Department of Medicine, University of California, San Diego, La Jolla, California, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Accelerating+COVID-19+Therapeutic+Interventions+and+Vaccines+%28ACTIV%29-2%2FA5401+Study+Team%2C+Study+Sites%2C+and+Investigators%22">Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-2/A5401 Study Team, Study Sites, and Investigators</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2025 Feb 04; Vol. 231 (1), pp. 131-136.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39400063
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/infdis/jiae501
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 131
    Titles:
      – TitleFull: Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Chew KW
      – PersonEntity:
          Name:
            NameFull: McGinley B
      – PersonEntity:
          Name:
            NameFull: Moser C
      – PersonEntity:
          Name:
            NameFull: Li JZ
      – PersonEntity:
          Name:
            NameFull: Evering TH
      – PersonEntity:
          Name:
            NameFull: Ritz J
      – PersonEntity:
          Name:
            NameFull: Javan AC
      – PersonEntity:
          Name:
            NameFull: Margolis D
      – PersonEntity:
          Name:
            NameFull: Wohl DA
      – PersonEntity:
          Name:
            NameFull: Hughes MD
      – PersonEntity:
          Name:
            NameFull: Daar ES
      – PersonEntity:
          Name:
            NameFull: Currier JS
      – PersonEntity:
          Name:
            NameFull: Eron JJ
      – PersonEntity:
          Name:
            NameFull: Smith DM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 02
              Text: 2025 Feb 04
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6613
          Numbering:
            – Type: volume
              Value: 231
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: The Journal of infectious diseases
              Type: main
ResultId 1